Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants

Regina Heidenreich, Marcia Machein, Anke Nicolaus, Andreas Hilbig, Carola Wild, Matthias Clauss, Karl H. Plate, Georg Breier

Research output: Contribution to journalArticle

39 Scopus citations


Vascular endothelial growth factor (VEGF) and the high-affinity VEGF receptor Flk-1/KDR (VEGFR-2) are key regulators of tumor angiogenesis. Strategies to block VEGF/VEGFR-2 signaling were successfully used to inhibit experimental tumor growth and indicated that VEGFR-2 is the main signaling VEGF receptor in proliferating tumor endothelium. Here, we investigated the role of the VEGF receptor-1 (VEGFR-1/Flt-1) in the vascularization of 2 different experimental tumors in vivo. VEGFR-1 mutants were generated that lack the intracellular tyrosine kinase domain. Retrovirus-mediated gene transfer of the VEGFR-1 mutants led to a strong reduction of tumor growth and angiogenesis in xenografted Co glioma and in syngeneic BFS-1 fibrosarcoma. Histological analysis of the inhibited fibrosarcoma revealed reduced vascular density, decreased tumor cell proliferation as well as increased tumor cell apoptosis and the formation of necrosis. The retroviral gene transfer of the full length VEGFR-1 also caused a significant reduction of tumor growth in both models. The inhibitory effects of the VEGFR-1 mutants and the full length VEGFR-1 in BFS-1 fibrosarcoma were mediated through host tumor endothelial cells because the BFS-1 fibrosarcoma cells were not infected by the retrovirus. The formation of heterodimers between VEGFR-2 and full length or truncated VEGFR-1 was observed in vitro and might contribute to the growth inhibitory effect by modulating distinct signal transduction pathways. The results of our study underline the central role of the VEGF/VEGFR-1 signaling system in tumor angiogenesis and demonstrate that VEGFR-1 can serve as a target for anti-angiogenic gene therapy.

Original languageEnglish (US)
Pages (from-to)348-357
Number of pages10
JournalInternational Journal of Cancer
Issue number3
StatePublished - Sep 1 2004
Externally publishedYes


  • Fibrosarcoma
  • Glioma
  • Tumor angiogenesis
  • VEGF receptor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants'. Together they form a unique fingerprint.

  • Cite this

    Heidenreich, R., Machein, M., Nicolaus, A., Hilbig, A., Wild, C., Clauss, M., Plate, K. H., & Breier, G. (2004). Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants. International Journal of Cancer, 111(3), 348-357.